Recurrent Preschool Wheeze: Asthma, Viral Wheeze or Something Else?
A 4-year-old girl is brought to clinic with her third emergency-department visit for wheeze in the past year; she has had seven episodes of cough and wheeze, all beginning with a cold. She is well between episodes, although she has eczema and allergic rhinitis. Her father has asthma and her mother smokes indoors. She attends daycare. Examination: temperature 36.9°C, respiratory rate 28/min, oxygen saturation 97% on room air, mild expiratory wheeze, no clubbing, and no failure to thrive. She improves after salbutamol and oral prednisolone in the emergency department. Chest radiograph is normal. The parents ask whether she has asthma and whether she needs a daily inhaler. There is no history of choking, recurrent pneumonia, chronic wet cough or neonatal respiratory distress. Her weight is on the 50th percentile.
1. How would you assess the probability of asthma in this preschool child, and what features support or argue against it?
Read the worked answer
This child has a high probability of recurrent wheeze with an asthma-like pattern. The Asthma Predictive Index is positive when a child has at least four wheeze episodes in a year plus one major criterion, such as parental asthma or eczema, or two minor criteria, such as allergic rhinitis, wheezing apart from colds or blood eosinophilia. She meets the major criterion of eczema and parental asthma and also has allergic rhinitis, so she is at high risk of persistent asthma.
The fact that episodes are triggered by colds does not exclude asthma in a preschool child; viral infections are the commonest trigger. However, the diagnosis remains clinical because spirometry is unreliable at this age. Features that would argue against simple asthma include chronic wet cough, clubbing, failure to thrive, recurrent pneumonia, neonatal respiratory distress, choking episodes or focal persistent signs. None are present, and the normal chest radiograph is reassuring. The judgement is to treat a high-risk phenotype while keeping the differential open if she fails to respond. A therapeutic trial with objective review is more useful than waiting for a definitive test that does not exist at this age.
2. What treatment plan and follow-up would you recommend, including inhaler strategy and when to refer?
Read the worked answer
She should start a daily inhaled corticosteroid trial for about 3 months, delivered by a metered-dose inhaler with a valved holding chamber and age-appropriate mask or mouthpiece. A low-dose preparation such as fluticasone propionate or budesonide is appropriate, with salbutamol as needed for acute symptoms. The parents need hands-on teaching, a written asthma action plan, and clear instructions about when to seek urgent care. Indoor smoking must be addressed with cessation support for the mother, because smoke exposure increases exacerbations.
Allergic rhinitis should be treated, and vaccinations should be up to date. Follow-up should be scheduled within 4–8 weeks and again at the end of the trial to assess daytime symptoms, night waking, reliever use, exacerbations and growth. If control is good, consider stepping down to the lowest effective dose; if control remains poor despite confirmed adherence and technique, reassess the diagnosis. Referral to pediatric pulmonology is warranted for atypical features, frequent exacerbations requiring oral steroids, poor response to a properly administered ICS trial, or concern about cystic fibrosis, primary ciliary dyskinesia, foreign body or immunodeficiency. The key is not to label the child forever after one visit, but also not to undertreat a high-risk preschool phenotype.